Is ARIA drug approval enough for a gap fill?

368 2 0
How are you going to trade this breakout inside the gap? http://goo.gl/jGvOaX

Ariad Pharmaceuticals Inc             ., the cancer-drug maker that had lost about 70 percent of its value this year, will return its only product (cleared last year for certain types of leukemia) to the U.S. market after regulators approved a new prescribing and risk management plan.

Sales of the drug were halted in the U.S. in October after regulators saw an increased risk of blood clots.


If October's gap down is filled, a long position opened today with a $4.50 stop loss has a potential Risk/Reward ratio of 2.

What do you think of the gap at the ARIA stock chart?
Be careful if you're a swing trader because of the shooting star
Nice pick, I am also looking for a rebound here, strong bounce on heavy volume, a potential technical bottom formation. But Today's late session retreat is a bit concerning for me, I would like to see price hold above this $6 handle next week.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out